Hantz Financial Services Inc. raised its position in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 3,126.1% in the third quarter, Holdings Channel reports. The firm owned 60,941 shares of the medical equipment provider’s stock after buying an additional 59,052 shares during the period. Hantz Financial Services Inc.’s holdings in Align Technology were worth $8,080,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of Align Technology in the 2nd quarter valued at approximately $745,370,000. Assenagon Asset Management S.A. increased its holdings in Align Technology by 638.7% in the third quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock worth $629,469,000 after buying an additional 4,031,284 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its position in Align Technology by 3,162.7% during the third quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock valued at $278,342,000 after acquiring an additional 2,033,451 shares in the last quarter. Vontobel Holding Ltd. raised its position in Align Technology by 69,628.9% during the third quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider’s stock valued at $183,335,000 after acquiring an additional 1,383,526 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in Align Technology by 4.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,054,633 shares of the medical equipment provider’s stock valued at $180,796,000 after acquiring an additional 49,220 shares in the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.
Align Technology Stock Performance
Shares of NASDAQ ALGN opened at $168.32 on Monday. The firm has a market cap of $11.86 billion, a price-to-earnings ratio of 24.50, a P/E/G ratio of 2.18 and a beta of 1.74. The business’s 50-day simple moving average is $151.67 and its 200-day simple moving average is $168.57. Align Technology, Inc. has a 52 week low of $130.23 and a 52 week high of $200.43.
Align Technology (NASDAQ:ALGN – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating analysts’ consensus estimates of $2.77 by $0.03. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. During the same period last year, the business earned $2.61 EPS. The firm’s revenue was up 1.9% compared to the same quarter last year. As a group, equities research analysts forecast that Align Technology, Inc. will post 9.21 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the stock. Morgan Stanley reduced their target price on shares of Align Technology from $188.00 to $175.00 and set an “equal weight” rating for the company in a research note on Thursday, October 29th. Weiss Ratings upgraded shares of Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Stifel Nicolaus dropped their price target on shares of Align Technology from $210.00 to $175.00 and set a “buy” rating on the stock in a research note on Friday, October 9th. Raymond James Financial restated a “buy” rating on shares of Align Technology in a report on Monday, October 5th. Finally, Piper Sandler reduced their price objective on shares of Align Technology from $235.00 to $205.00 and set an “overweight” rating for the company in a research note on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Align Technology has an average rating of “Moderate Buy” and a consensus price target of $193.08.
Read Our Latest Analysis on ALGN
About Align Technology
Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.
See Also
- Five stocks we like better than Align Technology
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.
